Last update:

Ophthalmology news

Low dose atropine eye drops safe and effective for short-sightedness in children, clinical trial suggests

Low-concentration atropine eye drops are a safe and effective treatment for short-sightedness (myopia) in UK children, although the effects are small, suggests a clinical trial published by The BMJ.

Researchers identify which eye infections pose greatest threat to vision

Eye surgery today is safer than ever, yet ophthalmologists must remain watchful for a rare but serious complication that can threaten sight within days: a bacterial eye infection called endophthalmitis. Now, clinician-scientists ...

Lab-grown aging eye model reveals early AMD markers in weeks

The rods and cones in your eyes are responsible for helping you see, but what is responsible for helping them? Retinal pigment epithelium cells are their caretakers, but environmental, genetic and aging factors can strain ...

New genetic map of the human eye reveals clues to vision loss

An international team led by University of Manchester scientists has created the most detailed picture yet of how genetic differences shape the way the human eye works. The breakthrough could help explain why millions of ...

Eye drop formulation can treat dry eye disease

Researchers at Baylor College of Medicine and Okayama University in Japan have developed and tested in mice a promising new eye drop formulation for treating dry eye disease. The team reports in Investigative Ophthalmology ...

Project expands access to care for children with amblyopia

A group of pediatric eye disease researchers has launched an open-access tool designed to help manage pediatric cases of amblyopia, a condition in which the brain fails to properly develop normal vision in one or both eyes ...

Low-dose eye drops can manage adult myopia for 24 hours

Groundbreaking research from the University of Houston shows that a single low-dose atropine eye drop can produce daylong effects in managing myopia, or nearsightedness, which affects roughly one-third of U.S. adults. Professor ...

Seeing keratoconus earlier with light polarization and AI

Keratoconus is a progressive eye disease that weakens and thins the cornea, the clear front surface of the eye. In its early, subclinical stage, the cornea can still appear normal on routine exams. Yet this is when accurate ...

Uniquely shaped microstent developed to combat glaucoma

A team of researchers at the University of Oxford have unveiled a pioneering "microstent" which could revolutionize treatment for glaucoma, a common but debilitating condition. The study has been published in The Innovation.

An alternative to LASIK—without the lasers

Millions of Americans have altered vision, ranging from blurriness to blindness. But not everyone wants to wear prescription glasses or contact lenses. Accordingly, hundreds of thousands of people undergo corrective eye surgery ...

Longer lashes, lasting damage? What to know about lash serums

Longer, darker lashes are having a moment. For those avoiding the risk or expense of lash extensions, serums can seem like a safer, more affordable option. But not all lash serums are created equal—and some come with hidden ...